Biobase Blood Coagulation Analyzer Bk-Ca02 Clinical Analytical Machine

Name: Biobase Blood Coagulation Analyzer Bk-Ca02 Clinical Analytical Machine
Brand: Biobase Biolin Co., Ltd.
SKU: 2059467992

Shandong, ChinaBiobase Biolin Co., Ltd.

US$390.00-500.00

1 Unit

Sample price:US$455.00/unit.Request sample

Product profile

Customization

Available

Classification

Biochemical Apparatus

Type

Biochemistry Analyzer

Model NO.

BK-CA02

Certification

CE, ISO13485

Model

Bk-Ca02

Test Principle

Optical Colorimetry

Test Items

PT, Aptt, Tt, Fib

Test Channel

Wavelength

470nm

Sample Incubation Position

Reagent Incubation Position

Detection Position Temperature

37.0±1.0°C

Incubation Position Temperature

37.0±1.0°C

Incubation Time

1~999s

Reaction Time

1~99s

Sample Volume

20-40

Printer

Built-in Thermal Printer

Package Size(W* D*H)

376*246*316mm

Gross Weight

5kg

Transport Package

Wooden, Carton Box

Specification

360*210*120mm

Trademark

BIOBASE

Origin

China

Production Capacity

5000/Year

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceMulti-language PioneerExperienced Team

Biobase Biolin Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 8.5 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤3.72h

AI-Powered supplier vetting

SummaryThe supplier is identified as a limited trading company in Jinan, offering laboratory equipment, medical devices, biochemistry analyzers, autoclaves, biological safety cabinets, and related products. It reports ODM, OEM, professional technical, 3D design, and flexible customization capabilities, along with overseas service offerings and a stated export-sales share of 90%. Service procedures are mixed: complaint handling and corrective/preventive action procedures have records, while effective service-capability assessment procedures lack written procedures and records. No overseas showroom, agent, branch, offline trade-show participation, SDK, or new-product launch is reported. Production quantities are stated for three products, but the supplier’s manufacturing status is unclear because it is classified as a trading company.

Supplier typeThe supplier is explicitly classified as a Trading Company and Limited Company, with a business scope centered on sales of medical equipment, office supplies, software, electronic products, and related items. It is not identified as part of a larger company group, and its associated industry is wholesale and retail.

After-Sales capabilityThe supplier reports overseas training, equipment installation, repair, maintenance, and debugging services, with 10 qualified service suppliers and stated lead times of within 15 working days off-season and one month during peak season. Complaint handling and corrective/preventive-action procedures have records, but the assessment procedure for effective service capability lacks written procedures and records; there are also no overseas showrooms, agents, branches, or offline trade-show experience.

R&D capabilityThe supplier reports ODM service, professional technical R&D capability, 3D software design, and flexible customization. However, it reports no new products launched in the past year and no available SDK, while product-information R&D capability is also marked as absent.

Customization capabilityThe supplier explicitly provides ODM services, 3D software design services, and flexible customization through its design and R&D capabilities. These statements directly support the availability of customized design or product solutions.